Bonaventure Equity, LLC — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
NaluBio, Inc.nalubio.cominJan 2023
Nalu Bio develops an AI-powered drug discovery platform targeting the endocannabinoid system to create therapeutics for inflammatory, immune, and metabolic diseases.
AI & Machine LearningBiotechHealthtechMedical DevicesSan Francisco, US
Caitlyn Krebs(Co-founder + CEO)Phyllis Whiteley(Co-founder + Board Member)Randall Ussery(Co-founder + Board Member)Phyllis E. Whiteley(Executive Officer, Director)Howard Goodwin(Director)Randall S. Ussery(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.